三维介孔氨基三亚甲基膦酸锆的合成及其担载铁催化剂的甲醛催化氧化活性

以氧氯化锆和氨基三亚甲基膦酸(ATMP)为原料合成了一种新型介孔材料氨基三亚甲基膦酸锆(NTAZP)。使用XRD、FTIR、TG-DTA和SEM等手段对所合成的介孔材料进行了结构表征和形貌分析。然后以NTAZP为载体,用Fe(NO3)3水溶液处理,得到担载Fe3+的氨基三亚甲基膦酸锆。研究结果表明,Fe3+被吸附到载体孔道中后,NTAZP结构未被破坏,Fe3+离子与NTAZP孔壁骨架上的N发生了配位作用。铁担载NTAZP(NTAZP-Fe3+)对甲醛氧化具有良好的催化活性,催化反应条件温和,催化剂稳定性良好。以载体NTAZP担载铁还避免了Fe3+进入水体,催化剂得以回收利用,避免造成二次污染。NTAZP-Fe3+是一种高效绿色的新型小分子醛类化合物氧化催化剂。     

介孔金属膦酸盐杂化材料研究进展

介孔金属有机膦酸盐杂化材料由于同时结合了无机和有机组分的性质,可作为一种环境友好的多功能材料而备受关注. 介孔金属有机膦酸盐中的有机和无机组分不是简单的物理混合,而是在分子尺度上的融合. 合成膦酸盐所需有机前驱体主要为有机多聚膦酸及其相应的盐和酯类化合物,种类繁多,使得各种有机官能团被均匀地引入进金属膦酸盐的骨架中,呈现多功能作用,有效地扩展了其应用领域. 本文系统地综述了介孔金属有机膦酸盐的合成及在吸附、分离、催化、生物传感和药物控释等领域应用研究进展,并对介孔金属膦酸盐材料的发展方向和应用前景进行了展望.     

叶酸修饰碳纳米管的合成及其负载伊立替康的释放

以叶酸改性壳聚糖修饰的碳纳米管为药物载体,选用治疗结肠癌的抗癌药物伊立替康为模型药物,通过非共价包覆的方式制备具有靶向功能的碳纳米管基药物载体材料。采用FT—IR、UV和TGA等对各阶段产物进行表征,考察了纳米载体的载药率和药物体外释放性能。结果表明,模型药物成功加载到了功能化的碳纳米管上,其栽药量达63．6％,包封率为85．92％。体外释放实验显示靶向功能化碳纳米管对伊立替康具有缓释作用,药物在37℃,pH-7．4的PBS缓冲溶液中能持续释放70h以上。     

5-氟尿嘧啶在pH敏感型分子筛控释载体中的缓释行为

以肠溶性的羟丙基甲基纤维素邻苯二甲酸酯(HPMCP)作为包覆材料,制备了HPMCP包覆的SBA-15介孔分子筛药物控释载体(HPMCP/SBA-15),并考察了抗癌药物5-氟尿嘧啶(5-Fu)负载于控释载体后,在不同pH释放环境中的释放行为.结果表明,在模拟胃液中(pH=1.2),HPMCP能明显地延缓5-Fu的释放速度;药物释放4h后,其释放率仅为15%.而在模拟肠液中(pH=7.5)HPMCP迅速溶解,对5-Fu释放速度的影响甚微;药物释放4h后,释放率可达到80%.与此同时,包覆膜的干燥温度影响5-Fu的释放行为,干燥温度越高,药物在模拟胃液中的释放速度越慢.     

介孔分子筛孔道结构对药物巯甲丙脯酸释放性能的影响

以巯甲丙脯酸为药物模型, 研究了不同孔道结构的介孔分子筛载体的药物释放性能.     

多重响应性介孔二氧化硅纳米微球的制备及载药研究

采用溶胶凝胶法制备了以油酸稳定的Fe3O4为核, 十六烷基三甲基溴化铵(CTAB)为模板剂的磁响应性的介孔二氧化硅纳米微球; 通过孔道内修饰羧基和巯基, 链转移反应修饰线性的聚(N-异丙基丙烯酰胺-co-N-羟甲基丙烯酰胺)共聚物得到多重响应性的介孔二氧化硅纳米微球P(NIPAM-co-NHMA)@M-MSN(-COOH). 利用Brunauer-Emmett-Teller (BET)、振动样品磁强计(VSM)、透射电子显微镜(TEM)、紫外光谱(UV/Vis)表征了微球的物理化学性质. 阿霉素(DOX)被用作模型药物研究了这种多重响应性的介孔二氧化硅纳米微球作为药物载体的载药及药物释放行为, 结果显示这种纳米微球载药率高达48%, 药物释放呈现对温度和pH的双重响应性, 可以实现对药物的控制释放.     

Fe3O4@mMoO3介孔多功能纳米载体的制备及其微波响应药物传递

以氨基功能化的Fe_3O_4纳米颗粒为磁核,结合直接沉淀法和模板法在其表面包覆上介孔MoO_3层,制备磁性-微波热转换性-介孔结构于一体的多功能核-壳结构复合纳米载体Fe_3O_4@mMoO_3,并对其结构、载药及微波控制靶向给药性进行研究。TEM图表明所得的复合纳米载体具有明显的核壳结构,完美的球形,且壳层中有清晰的孔状结构。磁性和微波热转换特性分析表明,该复合载体兼具良好的磁性和微波热转换特性,可实现药物的靶向可控给药。以布洛芬(IBU)为模型药物,对该复合纳米载体的药物负载能力和微波响应可控释放性进行研究,结果表明,在持续微波辐射90 s时IBU的释放率达到90%,远远高于仅搅拌时的释放率。     

酮洛芬/酸改性蒙脱土缓释体系的制备及体外释药研究

以盐酸改性蒙脱土为药物载体,采用离子交换法制备了酮洛芬/酸改性蒙脱土(KPF/acid-MMT)复合物.借助X射线衍射(XRD)、比表面积分析和扫描电子显微镜(SEM)等手段对复合物进行了结构表征;采用透析法研究了介质pH值对KPF/acid-MMT释放性能的影响;运用3种数学模型对其体外释放行为进行拟合.结果表明:经酸改性后,蒙脱土的比表面积由19.66 m~2/g增加到202.84 m~2/g,载药量由18.09%提高到37.24%;在人工模拟胃液(pH=1.2)和人工模拟肠液(pH=6.8)中,酮洛芬的累积释放量分别为18.6%和86.7%;零级动力学模型能更好地拟合和描述KPF/acid-MMT在人工模拟肠液中的体外释放行为.酸改性蒙脱土能有效提高药物的负载量,KPF/acid-MMT可实现药物的定向释放和缓释性能,有望制成肠道缓释口服药物制剂.     

叶酸功能化介孔碳纳米球负载阿霉素的细胞靶向传递及可控释放

以粒径90 nm的介孔碳纳米球作为靶向传药载体, 采用酸化处理改进了材料表面的亲疏水性及在溶液中的分散性, 通过壳寡糖功能化, 并利用EDC-NHS将叶酸修饰到介孔碳纳米球表面. 通过共聚焦激光扫描显微镜及流式细胞仪对实验体系的系统研究, 结果表明基于叶酸功能化的介孔碳纳米球能够有效提高负载药物对于HeLa细胞的跨膜转运效率, 叶酸阳性表达的HeLa细胞对于叶酸修饰的介孔碳纳米小球的吞噬效率明显高于叶酸阴性表达的MCF-7细胞. 对HeLa细胞毒性的定量分析表明叶酸的靶向作用在提高介孔碳纳米球内吞效率的同时, 进一步提高了阿霉素对于HeLa细胞的毒性.     

pH响应的介孔二氧化硅纳米颗粒的制备及可控释放

选择带负电荷且溶解度和分子结构对pH值非常敏感的聚丙烯酸作为封堵分子, 采用静电吸附的修饰方法, 制备了pH响应的MCM-41型介孔二氧化硅纳米颗粒. 利用高倍透射电子显微镜(TEM)、 X射线衍射(XRD)、 傅里叶变换红外光谱(FTIR)及比表面积分析等手段表征了介孔二氧化硅纳米颗粒的物理化学性质. 以联钌吡啶染料分子作为模式客体分子, 研究了pH调控下的模式客体分子在介孔二氧化硅纳米颗粒中的包裹及释放行为. 结果表明, 该介孔二氧化硅纳米颗粒对pH具有很好的响应性; 在近中性条件下, 带正电的二氧化硅纳米颗粒通过静电吸附作用吸附带负电的聚丙烯酸, 导致介孔封堵, 使包载的染料分子几乎无释放; 客体分子的释放率随着pH值的降低而升高, 当pH≤5时, 染料分子显著释放, pH=1时客体分子的释放率高达98％, 可以实现对包载客体分子的控制释放. 该pH响应的介孔二氧化硅纳米颗粒载体具有制备简便、 价格低廉和包载量大等优点, 有望应用于药物的控制释放.     

麦饭石含量对载药复合凝胶小球释药性能的影响

以瓜尔胶-g-聚丙烯酸/麦饭石复合水凝胶(GG-g-PAA/MS)和海藻酸钠(SA)为原料,双氯芬酸钠(DS)为模拟药物,采用离子凝胶法制备了载药复合凝胶小球,考察了pH敏感性以及MS含量对复合凝胶小球的包封率、载药率、溶胀性和药物释放行为的影响.结果表明:凝胶小球具有明显的pH敏感性,在不同pH介质中溶胀率和释放速率...     

Pore-size tunable mesoporous zirconium organophosphonates with chiral L-proline for enzyme adsorption

Mesoporous zirconium organophosphonates with a tunable mesopore (pore diameter: from 4.8 to 16.3 nm) were synthesized through co-condensation of ZrCl4 and 1-phosphomethylproline (H3PMP) with the aid of organic additives in the presence of an anionic surfactant (sodium dodecyl sulfate) under weak acidic conditions. The organic additives, tetrahydrofuran, can effectively strengthen the assembly of ZrCl4 and H3PMP around the surfactant micelles through decreasing the hydrolysis and condensation rate of ZrCl4. The results of the N2 sorption isotherm and SEM image show that zirconium phosphate with a bimodal structure is formed by calcination of mesoporous zirconium organophosphonate. Mesoporous zirconium organophosphonates can effectively adsorb lysozyme (Lz) and papain, and the adsorption equilibrium for Lz can be reached within 30 min. The adsorption capacity for Lz and papain can reach as high as 438 and 297 mg/g, respectively. Furthermore, Lz adsorbed on mesoporous zirconium organophosphonates can retain its structural conformation as in its free state, and no leaching of Lz from the solid was observed when shaking the Lz-loaded solid in a buffer solution. Also, the existence of L-proline in the mesopore could help the adsorption of papain at a pH value lower than the pI of papain.     

Poly(acrylamidoglycolic acid) nanocomposite hydrogels reinforced with cellulose nanocrystals for pH-sensitive controlled release of diclofenac sodium

In this study, a non-cytotoxic and pH-sensitive poly(acrylamidoglycolic acid) based nanocomposite (PAGA-NC) hydrogels reinforced with cellulose nanocrystals (CNCs) was synthesized using redox free radical polymerization. The successful formation and crystalline behaviour of PAGA-NC hydrogels was verified by fourier transform infrared (FTIR) spectroscopy and X-ray diffraction (XRD) analyses. The results showed that morphological, rheological and mechanical properties of the PAGA-NC hydrogels were strongly influenced by the CNCs content. Moreover, swelling properties were investigated, and the results suggested that they behaved as pH sensitive manner. The in vitro MTT assay showed that the PAGA-NC hydrogels are cytocompatibile to NIH-3T3 fibroblast cells. In addition, diclofenac sodium (DCF) model drug was successfully encapsulated into these PAGA-NC hydrogels via equilibrium swelling method. The in vitro release of DCF from PAGA-NC hydrogels was retained at pH 1.2 and maximum release was observed at 7.4, revealing as potential candidates for controlled release carriers for oral drug delivery applications.     

pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids

Acid-decomposable, luminescent ZnO quantum dots (QDs) have been employed to seal the nanopores of mesoporous silica nanoparticles (MSNs) in order to inhibit premature drug (doxorubicin) release. After internalization into HeLa cells, the ZnO QD lids are rapidly dissolved in the acidic intracellular compartments, and as a result, the loaded drug is released into the cytosol from the MSNs. The ZnO QDs behave as a dual-purpose entity that not only acts as a lid but also has a synergistic antitumor effect on cancer cells. We anticipate that these nanoparticles may prove to be a significant step toward the development of a pH-sensitive drug delivery system that minimizes drug toxicity.     

Non-thermal synthesis of mesoporous zirconium silicate and its characterization

A simple and rapid method for synthesis of mesoporous zirconium silicate with high thermal stability has been developed using sodium silicate in place of costly silicon alkoxides as a silica source. The product was characterized by means of X-ray diffraction, Nitrogen sorption isotherms, FT-IR spectroscopy, transmission electron microscopy (TEM) and thermogravimetry analysis (TGA).     

P(VPBA-DMAEA) as a pH-sensitive nanovalve for mesoporous silica nanoparticles based controlled release

A pH-sensitive controlled release system was proposed in this work, which consists of mesoporous silica nanoparticles(MSNs) functionalized on the pore outlets with poly(4-vinylphenybronic acid-co-2-(dimethylamino)ethyl acrylate) [P(VPBA-DMAEA)]. Four kinds of P(VPBA-DMAEA)-gated MSNs were synthesized and applied for the p H-sensitive controlled release. The results showed that P(VPBADMAEA) can work as a p H-sensitive nanovalve. The release behavior of the hybrid nanoparticles could be adjusted by changing the mole ratio of VPBA and DMAEA. With the increasing of the mole ratio of VPBA,the leakage of the entrapped molecules in the pores of MSNs could be decreased at neutral and alkaline conditions. By altering the p H of buffer from 4.0 to 8.0, the valve could be switched ‘‘on' and ‘‘off'reversibly. In addition, cells viability results indicated that these P(VPBA-DMAEA)-gated MSNs had good biocompatibility. We believe that these MSNs based p H-sensitive controlled release system will provide a promising nanodevice for sited release of drug delivery.     

Characterization of factors affecting the release of low-solubility drug from prolonged release tablets

Diclofenac sodium (2-[(2,6-dichlorophenyl)amino]benzeneacetic acid monosodium salt) was investigated as a low-solubility drug and Naklofen^® retard prolonged release tablets, containing 100 mg of diclofenac sodium as a prolonged release lipophilic matrix system using factorial design approach. First, the solubility characteristics of diclofenac sodium in aqueous media with various ionic strengths, ionic compositions and pH in the range of 1-8 were determined. The obtained results showed that the solubility of diclofenac sodium depends mainly on pH of the aqueous medium and less on the composition and ionic strength of the medium. Next, the estimation of the effects of six different factors (type of the dissolution apparatus, rotation speeds of the stirring elements, pH, ionic strengths of dissolution medium, the applied salt, and the producer of the on-line connected dissolution apparatus and UV spectrophotometer) on the release of diclofenac sodium, using the two-level six-factorial design was investigated. It was found that rotation speeds of the stirring elements, pH, and ionic strengths of the dissolution medium have a significant impact on the drug release and should be further followed in future drug release analyses. The advantages of the factorial design approach are obvious in this work. It is a very economic way of obtaining the maximum amount of information in a short period of time, especially in the case of prolonged release formulations where each experiment requires at least 24 h.     

Kinetics and mechanism of the deep electrochemical oxidation of sodium diclofenac on a boron-doped diamond electrode

The kinetics and mechanism of the deep oxidation of sodium diclofenac on a boron-doped diamond electrode are studied to develop a technique for purifying wastewater from pharmaceutical products. The products of sodium diclofenac electrolysis are analyzed using cyclic voltammetry and nuclear magnetic resonance techniques. It is shown that the toxicity of the drug and products of its electrolysis decreases upon its deep oxidation.     

Preparation of pH-sensitive liposomes retaining SOD mimic and their anticancer effect

We prepared an anticancer drug based on a pH-sensitive liposome retaining Fe-porphyrin as an SOD mimic. The liposomes contained cationic/anionic lipid combinations and were composed of Fe-porphyrin, 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine, dimethylditetradecylammonium bromide, sodium oleate, and Tween-80. The Fe-porphyrin was released from the liposome at low pH, and the cytotoxicity for cancer cells by the liposome depended on the acidic environments of the endosomes in the cells. Furthermore, although the liposome exhibited an excellent anticancer effect on a gastric cancer cell line, the SOD activity of Fe-porphyrin was shown to have a significant influence on the cytotoxicity toward cancer cells. These findings suggest that the pH-sensitive liposome retaining the Fe-porphyrin as an SOD mimic promises to be a novel anticancer drug for endosomal escape.     

In vitro transport of sodium diclofenac across rat abdominal skin: effect of selection of oleaginous component and the addition of alcohols to the vehicle

The in vitro percutaneous transport of sodium diclofenac from various oil vehicles was examined using rat abdominal skin as a model skin membrane. The overall transport of diclofenac through the skin from the oleaginous vehicles was very poor because of a poor solubility of sodium diclofenac in nonpolar oils. To increase the solubility and the permeability of sodium diclofenac, ethanol and n-octanol were added to each oil (designated as the formulated vehicles). The addition of ethanol and n-octanol to the nonpolar vehicles resulted in an extreme increase in drug solubility in each vehicle, with a remarkable increase in the permeation of diclofenac. The effects of oil components in the formulated vehicle on the permeation of diclofenac across the skin were in the following order: squalane greater than or equal to squalene greater than liquid paraffin greater than middle chain triglyceride greater than olive oil greater than castor oil. In order to clarify the reason for the differences in permeation of diclofenac from these formulated vehicles, the release of diclofenac and n-octanol from these vehicles in vitro was studied. The release rates of n-octanol from the formulated vehicles were in the following order: liquid paraffin greater than squalene greater than or equal to squalane greater than middle chain triglyceride greater than or equal to olive oil greater than castor oil. On the other hand, a linear correlation was observed between the initial release rate of diclofenac from the formulated vehicle and the in vitro permeation of diclofenac through the vehicle to the skin.(ABSTRACT TRUNCATED AT 250 WORDS)